Visit https://www.peervoice.com/JTM860 to view the entire programme with slides. After completing “Treatment Gaps in T2DM and Obesity: Personalising Care for Better Outcomes”, participants will be able to: Describe unmet needs for patients with type 2 diabetes (T2DM) and obesity; Explain safety and efficacy of pharmacologic options for the management of patients with T2DM and obesity, such as incretins; Develop individualised therapeutic goals and strategies to improve outcomes for patients with T2DM and obesity.